A New York City, New York, London, U.K., and Carmel, IN based developing AI to increase efficiency between medical treatment & research by matching clinical trials with patients.
The company uses a partner network made up of 300+ patient advocacy groups, health portals, bloggers, lab and data partners, and social media to refer patients to clinical trials. Its areas of therapeutic focus includes:
- Allergy and Immunology
- Arthritis
- Autoimmune
- Cardiology
- CNS
- Dermatology
- Gastroenterology
- IBS
- Liver disease
- Metabolic
- Ophthalmology
- Rare disease
- Renal
- Respiratory
Timeline
TrialReach Raises $13.5M Series B To Match Patients To Clinical Trials
TrialReach, a startup focused on making clinical trials more accessible, has announced a £2 million ( $3.1 million) funding round in order to further develop its product.
Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016.
Funding rounds
Antidote.me raises $11M in Venture Round, September 2017
Antidote.me raised $3.2M in Series A Funding Round
Antidote.me raises $13.5M in Series B Funding round - February, 2015
Antidote.me raised $1,200,000 in Venture Round - October, 2011
Antidote.me raised an undisclosed amount on in Venture Round, April 2016
People
Kathleen Freeman
Vice President of Business Development
Further reading
6 Ways Patients Can Find Clinical Trials Worldwide
Web
November 9, 2017
Antidote Technologies Inc - Company Profile and News
Web
Antidote Technologies raises $11M to speed development of trial matching platform
Jeff Lagasse
Web
September 7, 2017
Antidote Technologies Unveils Smart COVID-19 Clinical Trial Search to Speed Up Treatment and Vaccine Research Worldwide
Business Wire
Web
April 14, 2020
Antidote Technologies' Laurent Schockmel Recognized as a Top 40 Healthcare Transformer
markets.businessinsider.com
Web
March 21, 2019
New LRA and Antidote Technologies Study Finds Clinical Trial Participation by Minorities Lagging - Lupus Research
Lupus Research Alliance
Web
February 20, 2020
TrialReach Raises $13.5M Series B To Match Patients To Clinical Trials
Steve O'Hear
Web
February 5, 2015
